期刊文献+

变性高效液相色谱法在FALS突变位点检测中的应用 被引量:1

Denaturing high performance liquid chromatography for detection of point mutation of familial ALS
下载PDF
导出
摘要 目的检测一个肌萎缩侧索硬化症(amyotrophic lateral sclerosis,ALS)家系的铜、锌超氧化物歧化酶(Cu/Zn superoxide dismutase,SOD1)基因的突变位点,同时观察变性高效液相色谱法(denaturing high performance liquid chromatography,DHPLC)的实用价值。方法对PCR-SSCP检测阴性的外显子,应用DHPLC法及DNA直接测序技术,再次进行SOD1基因的突变位点检测。结果经DHPLC检测,家系成员Ⅲ1SOD1基因的第4外显子有突变峰,DNA直接测序证实存在杂合子,发生了GAA→GGA错义突变,使编码的氨基酸由谷氨酸变为甘氨酸。结论DHPLC技术与PCR-SSCP相比有更高的敏感性,可作为大样本筛查突变位点的一种便捷可靠手段。 Objective To identify the point mutation of Cu/Zn superoxide dismutase(SOD1) gene in an amyotrophic lateral sclerosis(ALS) family and observe the value of denaturing high performance liquid chromatography(DHPLC). Methods DHPLC and DNA sequencing were used to examine SOD1 gene of the ALS family which had not been found mutation by PCR-SSCP. Results DHPLC tests proved double peaks in one member(Ⅲ_1), Which indicated the possibility of mutation in SOD1 exon 4. DNA sequencing revealed that there was a heterozygote,with mutation of GAA to GGA in exon 4, and with a substitution of glutacid by glycine. Conclusion As compared with PCR-SSCP, DHPLC technique has proved to be a rapid and reliable method for screening mutation site in large samples.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2005年第13期1374-1376,共3页 Journal of Third Military Medical University
基金 国家自然科学基金资助项目(30300116)~~
关键词 家族性肌萎缩侧索硬化症 铜、锌超氧化物歧化酶 变性高效液相色谱法 突变 familial amyotrophic lateral sclerosis Cu/Zn superoxide dismutase denaturing high performance liquid chromatography mutation
  • 相关文献

参考文献8

  • 1史树贵,廖平,潘登,李露斯.肌萎缩侧索硬化一家系报道[J].第三军医大学学报,2003,25(3):273-274. 被引量:8
  • 2史树贵,李露斯,陈康宁,刘昕.一个肌萎缩侧索硬化家系的SOD1基因突变[J].中华医学遗传学杂志,2004,21(2):149-152. 被引量:19
  • 3Beghi E, Mennini T. Basic and clinical research on amyotrophic lateral sclerosis and other motor neuron disorders in Italy: recent findings and achievements from a network of laboratories [ J ]. Neurol Sci, 2004, 25(Suppl 2): S41 - S60.
  • 4Orrell R W, Marklund S L, deBelleroche J S. Familial ALS is associated with mutations in all exons of SOD1: a novel mutation in exon 3 (Gly72Ser)[J]. J Neurol Sci, 1997, 153(1): 46-49.
  • 5Wiedau Pazos M, Goto J J, Rabizadah S. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis[J]. Science, 1996, 271(5248): 515 - 518.
  • 6Bruijn L I, Houseweart M K, Kato S, et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1 [J]. Science, 1998, 281(5384): 1851- 1854.
  • 7Guegan C, Prezedborski S. Programmed cell death in amyotrophic lateral sclerosis[J]. J Clin Invest, 2003, 111(2): 153- 161.
  • 8Kwok P Y, Chen X. Detection of single nucleotide polymorphisms[J]. Curr Issues Mol Biol, 2003, 5(2): 43 - 60.

二级参考文献13

  • 1[1]Walker M P, Schlaberg R, Hays A P. Absence of echovirus sequences in brain and spinal cord of amyotrophic lateral sclerosis patients[J]. Ann Neurol,2001,49(2):249-53.
  • 2[2]Viehaber S, Kuns D, Winkler K, et al. Mitochindrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis[J]. Brain, 2000, 123(7): 1339-1348.
  • 3Orrell RW, Habgood JJ, Gardiner I, et al. Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Neurolog
  • 4Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 1993, 362∶59-62.
  • 5Guegan C, Przedborski J. Programmed cell death in amyotrophic lateral sclerosis. J Clin Invest, 2003, 111∶153-161.
  • 6Yuan J, Yankner BA. Apoptosis in the nervous system. Nature, 2000, 407∶802-809.
  • 7Johnson WG. Late-onset neurodegenerative diseases-the role of protein insolubility. J Anat, 2000, 196∶609-616.
  • 8Jacobson J, Jonsson PA, Andersen PM, et al. Superoxide dismutase in CSF from amyotrophic lateral sclerosis patients with and without CuZn superoxide dismutase mutations. Brain, 2001,124∶1461-1466.
  • 9Ohi T, Saita K, Takechi S, et al. Clinical features and neuropathological fingings of familial amyotrophic lateral sclerosis with a His46Arg mutation in Cu/Zn superoxide dismutase. J Neurol Sci, 2002, 197∶73-78.
  • 10Kim NH, Kim HJ, Kim M, et al. A novel SOD1 gene mutation in a Korean family with amyotrophic lateral sclerosis. J Neurol Sci, 2003, 206∶65-69.

共引文献20

同被引文献10

  • 1史树贵,李露斯,陈康宁,刘昕.一个肌萎缩侧索硬化家系的SOD1基因突变[J].中华医学遗传学杂志,2004,21(2):149-152. 被引量:19
  • 2胡俊,李露斯,吴玉章,倪兵,史树贵.构建具有突变铜-锌超氧化物歧化酶绿色荧光真核表达载体[J].中国临床康复,2005,9(29):58-59. 被引量:2
  • 3[5]Velasco I,Velasco VMA,Salazar P,et al.Influence of serumfree medium on the expression of glutamate transporters and the susceptibility to glutamate toxicity in cultured cortical neurons.NeurosciRes.2003,71:811-818.
  • 4[6]Nelson R.Protein instability and altered folding associated with ALS.Lancet Neurol,2005,4:462.
  • 5[7]Bruijn LI,Houseweart MK,Kato S,et al.Aggregation and motor neuron toxicity of an ALS-liked SODlmutant independent from wild-type SOD1.Science,1998,281(5384):1851-1854.
  • 6[8]Pamphlett R,Kum-Jew S.Zinc in the spinal cord of a mutant SOD1 mouse model of ALS.Neuroreport,2003,14:547-549.
  • 7[9]Curti D,Rognoni F,Alimonti D,et al.SOD1 activity and protective factors in familial ALS patients with L84F SOD1 mutation.Amyotroph Lateral Scler Other Motor Neuron Disord,2002,3:115-122.
  • 8[10]Orrell RW,Marklund SI.,deBelleroche JS.Familial ALS is associated with mutations in all exons of SOD1:a novel mutation in exon 3 (Gly72Ser).J Neurol Sci,1997,153:46-49.
  • 9[11]Bush A I.Is ALS caused by an altered oxidative activity of mutant superoxide dismutase? Na Neurosci,2002,5:919-920.
  • 10史树贵,廖平,潘登,李露斯.肌萎缩侧索硬化一家系报道[J].第三军医大学学报,2003,25(3):273-274. 被引量:8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部